M3, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,614 JPY | -2.92% |
|
-4.50% | -30.84% |
| 04-29 | M3's Attributable Profit Drops 7.7% in Fiscal 2024 | MT |
| 04-29 | Jefferies Adjusts M3’s Price Target to 1,800 Yen From 2,200 Yen, Keeps at Hold | MT |
| Sales 2024 | 239B 1.53B 121B | Sales 2025 * | 263B 1.69B 133B | Capitalization | 1,096B 7.04B 554B |
|---|---|---|---|---|---|
| Net income 2024 | 45.27B 291M 22.89B | Net income 2025 * | 47.73B 307M 24.14B | EV / Sales 2024 | 5.49 x |
| Net cash position 2024 | 139B 895M 70.49B | Net cash position 2025 * | 156B 1B 78.92B | EV / Sales 2025 * | 3.57 x |
| P/E ratio 2024 |
32
x | P/E ratio 2025 * |
23
x | Employees | 10,533 |
| Yield 2024 |
0.98% | Yield 2025 * |
1.39% | Free-Float | 60.21% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -2.92% | ||
| 1 week | -4.50% | ||
| Current month | -4.61% | ||
| 1 month | -16.51% | ||
| 3 months | -22.43% | ||
| 6 months | -34.41% | ||
| Current year | -30.84% |
1 week
1 598.50
1 768.00
1 month
1 598.501 926.00
Current year
1 598.502 527.50
1 year
1 598.503 388.00
3 years
1 598.508 945.00
5 years
1 598.5010 675.00
10 years
673.5010 675.00
| Managers | Title | Age | Since |
|---|---|---|---|
Akihiko Tomaru
CEO | Chief Executive Officer | 51 | - |
Itaru Tanimura
PSD | President | 59 | 28/09/00 |
Kazuyuki Izumiya
BRD | Director/Board Member | 52 | 31/12/09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Itaru Tanimura
PSD | President | 59 | 28/09/00 |
Akinori Urae
BRD | Director/Board Member | 66 | 31/05/14 |
| Director/Board Member | 64 | 28/09/00 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 8.65% | 4 M€ | -5.89% | ||
| 5.00% | 6 M€ | +5.57% | ||
| 1.71% | 19 M€ | +6.81% | ||
| 1.32% | 64,792 M€ | +16.79% | ||
| 1.14% | 57 M€ | +17.70% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/05/24 | 1,614 | -2.92% | 4 713 500 |
| 16/05/24 | 1,662 | -2.03% | 4,021,700 |
| 15/05/24 | 1,696 | +1.01% | 3,510,100 |
| 14/05/24 | 1,680 | +3.07% | 3,569,100 |
| 13/05/24 | 1,630 | +0.37% | 3,177,400 |
Delayed Quote Japan Exchange, May 17, 2024 at 07:00 am
More quotes
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
Sector
Internet Services
Calendar
25/06/2024
- Shareholders Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
1,614
JPY
Average target price
2,263
JPY
Spread / Average Target
+40.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.84% | 7.27B | |
| +34.54% | 472B | |
| +6.66% | 138B | |
| +32.61% | 98.36B | |
| +6.99% | 93.44B | |
| +61.15% | 59.13B | |
| +18.75% | 47.5B | |
| +30.27% | 39.41B | |
| +0.13% | 35.99B | |
| +15.50% | 29.22B |
- Stock Market
- Equities
- 2413 Stock
